Zinc transporters as potential therapeutic targets: An updated review

J Pharmacol Sci. 2022 Feb;148(2):221-228. doi: 10.1016/j.jphs.2021.11.007. Epub 2021 Dec 2.

Abstract

Zinc is an essential trace element that plays important roles in the regulation of various physiological responses in the body. Zinc deficiency is known to cause various health problems, including dysgeusia, skin disorders, and immune disorders. Therefore, the maintenance of healthy zinc content in the body is critical to our healthy life. Zinc homeostasis is tightly controlled by two of the solute carrier protein families SLC30A and SLC39A, called zinc transporters. In the last decade, research on zinc biology has made dramatic progress based on the physiological and functional analysis of zinc transporters in the fields of molecular biology, human genetics, and drug discovery. In particular, since the association between zinc transporters and human diseases was recently reported using human genetics and gene knockout mouse studies, zinc and zinc signals controlled by zinc transporters have been considered useful therapeutic targets. In this review, we introduce the importance of zinc homeostasis based on the findings of zinc transporter functions and their signals in relation to human diseases.

Keywords: Diseases; Therapeutic target; Zinc homeostasis; Zinc signals; Zinc transporters.

Publication types

  • Review

MeSH terms

  • Animals
  • Carrier Proteins / metabolism*
  • Carrier Proteins / physiology*
  • Homeostasis
  • Humans
  • Mice
  • Mice, Knockout
  • Molecular Targeted Therapy*
  • Signal Transduction / physiology
  • Zinc / metabolism*
  • Zinc / physiology*

Substances

  • Carrier Proteins
  • zinc-binding protein
  • Zinc